Exosect announces new Chief Technology Officer

Exosect welcomes Aoife Dillon as new Chief Technology Officer
 
 
Aoife Dillon 1
Aoife Dillon 1
 
Spread the Word
Listed Under

Tags:
Entostat
Formulation Platform
Licensing
Biological
Chemical

Industrys:
Agriculture
Business

Location:
Winchester - Hampshire - England

Subject:
Executives

WINCHESTER, U.K. - April 29, 2015 - PRLog -- Winchester UK – Exosect, a leading provider of enabling technologies today announced the appointment of Dr. Aoife Dillon as Chief Technology Officer.  Aoife joins Exosect from BASF where she was Technical Specialist for Bio-insecticides.

Aoife gained her PhD in Integrated Pest Management at the National University of Ireland and brings with her over fifteen-years of experience in bio-insecticide development and delivery of IPM strategies. She will

lead the Technology Development team, overseeing all development programmes for Exosect’s licensing partners.

- Ends -

Notes to Editors


Entostat is an electrostatically charged micro-powder. A leading variant of Entostat is based on a carnauba wax blend that is chemically inert.

This variant of Entostat is sustainably harvested from the Brazilian Carnauba palm, Copernica Martius (Palmae). Other variants may include a range of natural and synthetic waxes and polymers.

Entostat is a non-hygroscopic electrostatic micro-powder that can be produced in a range of sizes and shapes. It can be formulated to microencapsulate synthetic active ingredients offering release retardation or to support biological active ingredients on its surface by electrostatic attraction.

Entostat readily gains an electrostatic charge, consequently it adheres to a range of surfaces including, grains and seeds, insects & animals, building fabrics.

It therefore has the potential to deliver an active ingredient at a reduced application rate with equivalent or improved efficacy.

About Exosect

Exosect was launched in 2001 to develop proprietary platforms technologies, initially for agriculture.

The company has developed an in-depth knowledge and extensive patent portfolio of the platforms as targeted delivery mechanisms for a range of active ingredients, biological and synthetic.

Today, the technology is enabling our partners across a range of sectors to realise the efficient delivery of their active ingredients, helping them to overcome issues such as pest resistance, regulatory controls and residues within the food chain.

Exosect is focussed on the Agriculture, Public Health and Animal Health sectors.

Media Contact
Georgina Donovan
***@exosect.com
End
Email:***@exosect.com Email Verified
Tags:Entostat, Formulation Platform, Licensing, Biological, Chemical
Industry:Agriculture, Business
Location:Winchester - Hampshire - England
Subject:Executives
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share